glp-1 insurance coverage for weight loss Medicaid of and Spending on GLP-1s GLP-1 medications are transforming medical

Wegovy is a registered trademark of Novo Nordisk A/S

Visit HealthVerity Marketplace to access robust, real-world data on GLP-1 therapies and other high-impact drugs

It probably is

While the potential cost of authorizing Medicare coverage of anti-obesity drugs has presented a barrier to enacting legislation to lift the prohibition, covering these drugs under Medicare for authorized uses has already catapulted these drugs to rank among the top-selling drugs covered by Part D, Medicares outpatient drug benefit program

Back Hendershot, CS, Bremmer, MP, Paladino, B, et al (12 Feb 2025) 'Once-weekly semaglutide in adults with alcohol use disorder: A randomized clinical trial', JAMA Network, 82/4, 395-405.Back 'Scientists pioneer two techniques to combat obesity', The Guardian

An additional abstract will provide early preclinical research on muscle biology.